0.002 |
squamous cell carcinoma |
NA |
GAD |
|
Detail |
0.003 |
Cardiovascular Diseases |
NA |
BeFree,GAD |
|
Detail |
0.002 |
brain ischemia |
NA |
GAD |
|
Detail |
0.002 |
Cerebrovascular Disorders |
NA |
GAD |
|
Detail |
<0.001 |
Malignant tumor of cervix |
NA |
BeFree |
|
Detail |
0.005 |
cleft lip |
NA |
GAD |
|
Detail |
0.005 |
cleft palate |
NA |
GAD |
|
Detail |
<0.001 |
Cognition Disorders |
Polymorphisms of genes involved in B vitamin absorption, metabolism and function... |
BeFree |
25173634 |
Detail |
0.003 |
ulcerative colitis |
NA |
BeFree,GAD |
|
Detail |
0.122 |
Colorectal Neoplasms |
NA |
CTD_human,GAD |
|
Detail |
0.006 |
Coronary Arteriosclerosis |
NA |
BeFree,GAD |
|
Detail |
0.003 |
Crohn Disease |
NA |
BeFree,GAD |
|
Detail |
0.002 |
Demyelinating Diseases |
NA |
GAD |
|
Detail |
<0.001 |
Mental Depression |
NA |
BeFree |
|
Detail |
<0.001 |
depressive disorder |
NA |
BeFree |
|
Detail |
0.003 |
Diabetes Mellitus, Insulin-Dependent |
NA |
BeFree,GAD |
|
Detail |
0.040 |
Down syndrome |
The MTRR 66A>G polymorphism and maternal risk of birth of a child with Down synd... |
BeFree,GAD,LHGDN |
24965145 |
Detail |
0.040 |
Down syndrome |
In conclusion, our meta-analysis suggested that the MTRR c.66A>G (rs1801394) pol... |
BeFree,GAD,LHGDN |
25544792 |
Detail |
0.002 |
drug allergy |
NA |
GAD |
|
Detail |
0.003 |
epilepsy |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Exanthema |
NA |
BeFree |
|
Detail |
0.002 |
Fetal Growth Retardation |
NA |
GAD |
|
Detail |
0.002 |
Folic Acid Deficiency |
NA |
GAD |
|
Detail |
0.005 |
Glioma |
NA |
GAD,LHGDN |
|
Detail |
0.120 |
IgA glomerulonephritis |
NA |
CTD_human |
|
Detail |
<0.001 |
gonorrhea |
In conclusion, the high level of resistance to quinolone and single or multiple ... |
BeFree |
25865983 |
Detail |
0.005 |
Head and Neck Neoplasms |
NA |
GAD,LHGDN |
|
Detail |
<0.001 |
Sensorineural Hearing Loss (disorder) |
NA |
BeFree |
|
Detail |
0.002 |
Heart Septal Defects |
NA |
GAD |
|
Detail |
0.003 |
hepatitis B |
NA |
BeFree,GAD |
|
Detail |
0.122 |
homocystinuria |
The prevalent c.903+469T>C mutation in MTRR causes the cblE type of homocystinur... |
BeFree,CTD_human |
25878036 |
Detail |
0.002 |
Huntington disease |
NA |
GAD |
|
Detail |
0.003 |
Hypertensive disease |
NA |
BeFree,GAD |
|
Detail |
0.002 |
Inflammatory Bowel Diseases |
NA |
GAD |
|
Detail |
<0.001 |
Kidney Diseases |
NA |
BeFree |
|
Detail |
0.005 |
chronic lymphocytic leukemia |
NA |
GAD |
|
Detail |
0.002 |
lymphoid leukemia |
NA |
GAD |
|
Detail |
0.001 |
Leukemia, Lymphocytic, Acute, L1 |
NA |
BeFree |
|
Detail |
<0.001 |
Leukemia, Myelocytic, Acute |
NA |
BeFree |
|
Detail |
0.002 |
Liver neoplasms |
NA |
GAD |
|
Detail |
0.003 |
Chronic Obstructive Airway Disease |
NA |
BeFree,GAD |
|
Detail |
0.002 |
Lung Neoplasms |
NA |
GAD |
|
Detail |
0.002 |
Lupus Erythematosus, Systemic |
NA |
GAD |
|
Detail |
0.002 |
Lymphoma, Follicular |
NA |
GAD |
|
Detail |
0.006 |
Lymphoma, Non-Hodgkin |
NA |
BeFree,GAD |
|
Detail |
0.002 |
Marijuana Abuse |
NA |
GAD |
|
Detail |
0.001 |
Carcinoma of lung |
SNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 9... |
BeFree |
23372658 |
Detail |
0.011 |
Malignant neoplasm of lung |
SNPs in MTRR (rs13162612; OR = 0.25; 95% CI: 0.11-0.58; rs10512948; OR = 0.61; 9... |
BeFree |
23372658 |
Detail |
0.002 |
melanoma |
NA |
GAD |
|
Detail |
0.002 |
Meningeal Neoplasms |
NA |
GAD |
|
Detail |
0.006 |
meningioma |
NA |
BeFree,GAD,LHGDN |
|
Detail |
0.002 |
Metabolic Diseases |
NA |
GAD |
|
Detail |
0.008 |
multiple myeloma |
NA |
BeFree,GAD,LHGDN |
|
Detail |
0.002 |
multiple sclerosis |
NA |
GAD |
|
Detail |
0.120 |
nervous system disorder |
NA |
CTD_human |
|
Detail |
0.024 |
Neural Tube Defects |
NA |
GAD,LHGDN |
|
Detail |
<0.001 |
Exanthema |
Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transfera... |
BeFree |
14716779 |
Detail |
<0.001 |
Spots on skin |
Genotyping for glutathione S-transferase micro1 (GSTM1), glutathione S-transfera... |
BeFree |
14716779 |
Detail |
0.003 |
obesity |
NA |
BeFree,GAD |
|
Detail |
0.002 |
oligospermia |
NA |
GAD |
|
Detail |
0.007 |
Pancreatic Neoplasm |
NA |
GAD,LHGDN |
|
Detail |
0.005 |
Parkinson disease |
NA |
GAD |
|
Detail |
0.002 |
Phenylketonurias |
NA |
GAD |
|
Detail |
0.002 |
placental insufficiency |
NA |
GAD |
|
Detail |
0.005 |
pre-eclampsia |
NA |
GAD |
|
Detail |
0.002 |
Pregnancy Complications, Cardiovascular |
NA |
GAD |
|
Detail |
0.002 |
Psychoses, Substance-Induced |
NA |
GAD |
|
Detail |
0.040 |
Down syndrome |
In the present study, we determined polymorphisms of MTHFR A222V (677C > T), ... |
BeFree |
15889417 |
Detail |
0.003 |
schizophrenia |
NA |
BeFree,LHGDN |
|
Detail |
0.005 |
Stomach Neoplasms |
NA |
GAD |
|
Detail |
0.010 |
Cerebrovascular accident |
NA |
BeFree,GAD,LHGDN |
|
Detail |
<0.001 |
Giant Cell Arteritis |
NA |
BeFree |
|
Detail |
<0.001 |
Thromboembolism |
NA |
BeFree |
|
Detail |
<0.001 |
Trisomy |
NA |
BeFree |
|
Detail |
0.120 |
Adverse reaction to drug |
NA |
CTD_human |
|
Detail |
0.003 |
Vascular Diseases |
NA |
BeFree,GAD |
|
Detail |
0.005 |
Venous Thrombosis |
NA |
GAD,LHGDN |
|
Detail |
0.002 |
Vitamin B Deficiency |
NA |
GAD |
|
Detail |
0.005 |
diffuse large B-cell lymphoma |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Lymphoma, Large-Cell, Follicular |
NA |
BeFree |
|
Detail |
0.005 |
T-Cell Lymphoma |
NA |
BeFree,GAD |
|
Detail |
0.020 |
spina bifida |
NA |
BeFree,GAD,LHGDN |
|
Detail |
<0.001 |
Deep Vein Thrombosis |
NA |
BeFree |
|
Detail |
<0.001 |
Small cell carcinoma of lung |
NA |
BeFree |
|
Detail |
<0.001 |
Migraine Disorders |
NA |
BeFree |
|
Detail |
0.005 |
Premature Birth |
NA |
GAD |
|
Detail |
0.002 |
Myocardial Ischemia |
NA |
GAD |
|
Detail |
<0.001 |
Deep thrombophlebitis |
NA |
BeFree |
|
Detail |
<0.001 |
congenital heart disease |
NA |
BeFree |
|
Detail |
<0.001 |
migraine with aura |
NA |
BeFree |
|
Detail |
0.002 |
adrenoleukodystrophy |
NA |
GAD |
|
Detail |
0.002 |
iron deficiency anemia |
NA |
GAD |
|
Detail |
0.002 |
Aortic Aneurysm, Abdominal |
NA |
GAD |
|
Detail |
<0.001 |
Cervical Intraepithelial Neoplasia |
NA |
BeFree |
|
Detail |
<0.001 |
pancreatic carcinoma |
NA |
BeFree |
|
Detail |
0.011 |
Malignant neoplasm of lung |
NA |
BeFree,GAD |
|
Detail |
0.005 |
age related macular degeneration |
NA |
GAD |
|
Detail |
<0.001 |
Xeroderma Pigmentosum, Complementation Group D |
NA |
BeFree |
|
Detail |
<0.001 |
adult meningioma |
NA |
BeFree |
|
Detail |
0.002 |
Cancer of Head and Neck |
NA |
GAD |
|
Detail |
<0.001 |
Squamous cell carcinoma of esophagus |
NA |
BeFree |
|
Detail |
0.003 |
cervix carcinoma |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Deep vein thrombosis of lower limb |
NA |
BeFree |
|
Detail |
<0.001 |
Malignant neoplasm of pancreas |
NA |
BeFree |
|
Detail |
0.003 |
Avitaminosis |
NA |
BeFree,GAD |
|
Detail |
0.010 |
Malignant neoplasm of prostate |
NA |
BeFree,GAD |
|
Detail |
0.002 |
Hematologic Neoplasms |
NA |
GAD |
|
Detail |
0.002 |
Malignant neoplasm of esophagus |
NA |
GAD |
|
Detail |
0.005 |
Methotrexate poisoning |
NA |
GAD |
|
Detail |
<0.001 |
Carcinogenesis |
NA |
BeFree |
|
Detail |
0.141 |
hyperhomocysteinemia |
Methionine synthase reductase (MTRR) plays a major role in hyperhomocysteinemia,... |
BeFree,CTD_human,GAD,LHGDN |
24913415 |
Detail |
<0.001 |
prostate carcinoma |
NA |
BeFree |
|
Detail |
0.005 |
Choroidal Neovascularization |
NA |
GAD |
|
Detail |
0.003 |
breast carcinoma |
NA |
BeFree |
|
Detail |
0.001 |
Carcinoma of lung |
NA |
BeFree |
|
Detail |
<0.001 |
Secondary malignant neoplasm of lymph node |
MTRR 66 GA + GG genotypes decreased the risk of death (HR = 0.793, 95% CI = 0.65... |
BeFree |
25840420 |
Detail |
0.002 |
Chronic progressive chorea |
NA |
GAD |
|
Detail |
<0.001 |
colon carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Carcinoma of bladder |
NA |
BeFree |
|
Detail |
0.002 |
Cardiac defects |
NA |
GAD |
|
Detail |
<0.001 |
Brain Tumor, Primary |
NA |
BeFree |
|
Detail |
<0.001 |
adult acute lymphocytic leukemia |
NA |
BeFree |
|
Detail |
0.002 |
Congenital omphalocele |
NA |
GAD |
|
Detail |
<0.001 |
Spots on skin |
NA |
BeFree |
|
Detail |
0.002 |
Carcinoma, Pancreatic Ductal |
NA |
GAD |
|
Detail |
<0.001 |
Metastatic Prostate Carcinoma |
NA |
BeFree |
|
Detail |
<0.001 |
Ischemic stroke |
NA |
BeFree |
|
Detail |
0.040 |
Down syndrome |
The aim of the present study was to investigate the effect of polymorphisms C677... |
BeFree |
18273817 |
Detail |
<0.001 |
Squamous cell carcinoma of the head and neck |
NA |
BeFree |
|
Detail |
<0.001 |
Adenoma of large intestine |
NA |
BeFree |
|
Detail |
<0.001 |
childhood leukemia |
NA |
BeFree |
|
Detail |
0.002 |
gastric cardia carcinoma |
NA |
GAD |
|
Detail |
0.003 |
Mammary Neoplasms |
NA |
LHGDN |
|
Detail |
<0.001 |
Vitamin Deficiency |
NA |
BeFree |
|
Detail |
0.002 |
Fetus affected by placental transfer of anticonvulsant |
NA |
GAD |
|
Detail |
<0.001 |
Meningioma, benign, no ICD-O subtype |
NA |
BeFree |
|
Detail |
0.009 |
Venous thromboembolism |
NA |
GAD |
|
Detail |
0.120 |
Neural tube defect, folate-sensitive |
NA |
CTD_human |
|
Detail |
0.006 |
coronary artery disease |
NA |
BeFree,GAD |
|
Detail |
0.005 |
liver carcinoma |
NA |
BeFree,GAD,LHGDN |
|
Detail |
<0.001 |
Hyperdiploid B Acute Lymphoblastic Leukemia |
NA |
BeFree |
|
Detail |
<0.001 |
Ischemic Cerebrovascular Accident |
NA |
BeFree |
|
Detail |
0.082 |
Homocysteinemia |
Methionine synthase reductase (MTRR) plays a major role in hyperhomocysteinemia,... |
BeFree,MGD |
24913415 |
Detail |
0.005 |
Hyperhomocystinemia |
NA |
GAD |
|
Detail |
0.005 |
Congenital Abnormality |
NA |
GAD |
|
Detail |
0.002 |
adenocarcinoma |
NA |
GAD |
|
Detail |
0.120 |
adenoma |
NA |
CTD_human |
|
Detail |
0.002 |
Alcoholic Intoxication, Chronic |
NA |
GAD |
|
Detail |
0.003 |
Alzheimer's disease |
NA |
LHGDN |
|
Detail |
<0.001 |
Anemia, Megaloblastic |
NA |
BeFree |
|
Detail |
<0.001 |
aortic aneurysm |
NA |
BeFree |
|
Detail |
<0.001 |
arteriosclerosis |
NA |
BeFree |
|
Detail |
0.010 |
rheumatoid arthritis |
NA |
BeFree,GAD,LHGDN |
|
Detail |
0.005 |
atherosclerosis |
NA |
BeFree,GAD |
|
Detail |
0.003 |
autistic disorder |
NA |
BeFree,GAD |
|
Detail |
0.003 |
bipolar disorder |
NA |
LHGDN |
|
Detail |
0.008 |
Malignant neoplasm of urinary bladder |
NA |
BeFree,GAD |
|
Detail |
0.002 |
Brain Neoplasms |
NA |
GAD |
|
Detail |
0.017 |
Malignant neoplasm of breast |
NA |
BeFree,GAD |
|
Detail |
<0.001 |
Malignant tumor of colon |
NA |
BeFree |
|
Detail |
0.003 |
Non-small cell lung carcinoma |
NA |
BeFree,GAD |
|
Detail |